Board of Aurobindo Pharma recommends interim dividend

Aurobindo Pharma announced that the Board of Directors of the Company at its meeting held on 4 November 2026, inter alia, have recommended the interim dividend of Rs 7 per equity Share (i.e. 700%) , subject to the approval of the shareholders.